Investor Update

Basel, 25 May 2012

New Drug Application Filed for Anti-Cancer Agent “Pertuzumab” for the Treatment of HER2-Positive Metastatic or Recurrent Breast Cancer

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.